GaPP: a pilot randomised controlled trial of the efficacy of action of gabapentin for the management of chronic pelvic pain in women: study protocol

Horne, A.W., Critchley, H.O.D., Doust, A., Fehr, D., Wilson, J., Wu, O. , Jack, S., Porter, M., Lewis, S. and Bhattacharya, S. (2012) GaPP: a pilot randomised controlled trial of the efficacy of action of gabapentin for the management of chronic pelvic pain in women: study protocol. BMJ Open, 2(3), e001297. (doi: 10.1136/bmjopen-2012-001297)

[img]
Preview
Text
77603 (1).pdf - Cover Image

62kB
[img]
Preview
Text
77603.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial.

343kB

Abstract

<p>Introduction Chronic pelvic pain (CPP) affects >1 million UK women. Annual healthcare costs are estimated at >£150 million. Proven interventions for CPP are limited, and treatment is often unsatisfactory. Gabapentin is increasingly prescribed due to reports of effectiveness in other chronic pain conditions, but there are insufficient data supporting value in CPP specifically. The mechanism by which gabapentin exerts its analgesic action is unknown. Given the prevalence and costs of CPP, the authors believe that a large, multicentre, placebo-controlled, double-blind randomised controlled trial to evaluate the efficacy of gabapentin in management of CPP is required. The focus of this study is a pilot to inform planning of a future randomised controlled trial.</p> <p>Methods and analysis The authors plan to perform a two-arm, parallel, randomised controlled pilot trial. The authors aim to recruit 60 women with CPP in NHS Lothian and NHS Grampian (UK) and randomise them to gabapentin or placebo. Response to treatment will be monitored by questionnaire compared at 0, 3 and 6 months. The primary objective is to assess recruitment and retention rates. The secondary objectives are to determine the effectiveness and acceptability to participants of the proposed methods of recruitment, randomisation, drug treatments and assessment tools and to perform a pretrial cost-effectiveness assessment of treatment with gabapentin.</p> <p>Ethics and dissemination Ethical approval has been obtained from the Scotland A Research Ethics Committee (LREC 12/SS/0005). Data will be presented at international conferences and published in peer-reviewed journals.</p>

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Wu, Professor Olivia
Authors: Horne, A.W., Critchley, H.O.D., Doust, A., Fehr, D., Wilson, J., Wu, O., Jack, S., Porter, M., Lewis, S., and Bhattacharya, S.
College/School:College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > Health Economics and Health Technology Assessment
Journal Name:BMJ Open
Publisher:BMJ Publishing Group
ISSN:2044-6055
Published Online:08 June 2012
Copyright Holders:Copyright © 2012 The Authors
First Published:First published in BMJ Open 2(3):e001297
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
565171Randomised controlled trial on the efficacy and mechanism of action of gabapentin for the management of chronic pelvic pain in womenOlivia WuScottish Executive Health Department (SEHHD-CSO)CZH/4/688IHW - HEALTH ECON & TECH ASSESSMENT